Expression of common housekeeping genes is affected by disease in human hepatitis C virus-infected liver

被引:23
|
作者
Congiu, Mario [1 ,2 ]
Slavin, John L. [3 ]
Desmond, Paul V. [1 ,2 ]
机构
[1] St Vincents Hosp Melbourne, Dept Gastroenterol, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, Dept Med, St Vincents Hosp Melbourne, Fitzroy, Vic 3065, Australia
[3] St Vincents Hosp Melbourne, Dept Pathol, Fitzroy, Vic 3065, Australia
关键词
fibrosis; HCV; housekeeping genes; inflammation; liver disease; MESSENGER-RNA LEVELS; REAL-TIME; RT-PCR; TRANSCRIPTION; PROTEIN;
D O I
10.1111/j.1478-3231.2010.02374.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Comparative gene expression is commonly determined with reference to the expression of a housekeeping gene (HKG), the level of which is assumed to be unregulated. There are little data to date on the effect of disease on the expression of classic HKGs in hepatitis C virus (HCV)-infected human liver. Aims To identity HKGs stable across a wide spectrum of disease in human HCV-infected liver. Methods beta-Actin, hypoxanthine phosphoribosyltransferase 1 (HPRT1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), splicing factor arginine/serine-rich 4, beta-glucuronidase and 18S ribosomal RNA (18S rRNA) were measured by real-time polymerase chain reaction in liver biopsy tissue. Samples were categorised for inflammation, fibrosis and steatosis, and allocated into groups with mild or severe liver disease. Values were analysed using Spearman's rank correlation, NormFinder, BestKeeper and geNorm programs. Results All genes performed well in the samples of patients with low disease activity, but HPRT1, beta-actin, GAPDH and 18S rRNA ranked poorly in samples with severe fibrosis or inflammation. Conclusions Our results indicate that liver disease affects the expression of common HKGs and that beta-glucuronidase and splicing factor arginine/serine-rich 4 are the most stable HKGs from this group for studies of gene expression in HCV-infected human liver.
引用
收藏
页码:386 / 390
页数:5
相关论文
共 50 条
  • [1] Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver
    Fujino, Tatsuya
    Nakamuta, Makoto
    Yada, Ryoko
    Aoyagi, Yoko
    Yasutake, Kenichiro
    Kohjima, Motoyuki
    Fukuizumi, Kunitaka
    Yoshimoto, Tsuyoshi
    Harada, Naohiko
    Yada, Masayoshi
    Kato, Masaki
    Kotoh, Kazuhiro
    Taketomi, Akinobu
    Maehara, Yoshihiko
    Nakashima, Manabu
    Enjoji, Munechika
    HEPATOLOGY RESEARCH, 2010, 40 (09) : 923 - 929
  • [2] Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts
    Vargas, HE
    Laskus, T
    Wang, LF
    Lee, R
    Radkowski, M
    Dodson, F
    Fung, JJ
    Rakela, J
    GASTROENTEROLOGY, 1999, 117 (01) : 149 - 153
  • [3] Hepatitis C virus-infected donors in liver transplantation
    Lang, Les
    GASTROENTEROLOGY, 2007, 133 (02) : 381 - 382
  • [4] Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals
    Susan E Buskin
    Elizabeth A Barash
    John D Scott
    David M Aboulafia
    Robert W Wood
    World Journal of Gastroenterology, 2011, 17 (14) : 1807 - 1816
  • [5] Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals
    Buskin, Susan E.
    Barash, Elizabeth A.
    Scott, John D.
    Aboulafia, David M.
    Wood, Robert W.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (14) : 1807 - 1816
  • [6] Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients
    Kiberd, Bryce
    Doucette, Karen
    Vinson, Amanda
    Tennankore, Karthik
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (12) : 897 - 898
  • [7] Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients
    Vargas, HE
    Laskus, T
    Radkowski, M
    Poutous, A
    Wang, LF
    Lee, R
    Dodson, F
    Gayowski, T
    Singh, N
    Marino, IR
    Fung, JJ
    ZhangKeck, ZY
    Kim, JP
    Rakela, J
    TRANSPLANTATION, 1997, 64 (05) : 786 - 788
  • [8] Dietary Fructose Intake and Severity of Liver Disease in Hepatitis C Virus-infected Patients
    Tyson, Gia L.
    Richardson, Peter A.
    White, Donna L.
    Kuzniarek, Jill
    Ramsey, David J.
    Tavakoli-Tabasi, Shahriar
    El-Serag, Hashem B.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (06) : 545 - 552
  • [9] Severity and correlates of liver disease in hepatitis C virus-infected injection drug users
    Rai, R
    Wilson, LE
    Astemborski, J
    Anania, F
    Torbenson, N
    Spoler, C
    Vlahov, D
    Strathdee, SA
    Boitnott, J
    Nelson, KE
    Thomas, DL
    HEPATOLOGY, 2002, 35 (05) : 1247 - 1255
  • [10] Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease
    Lawitz, E.
    Poordad, F.
    Gutierrez, J. A.
    Kakuda, T. N.
    Picchio, G.
    Beets, G.
    Vandevoorde, A.
    Van Remoortere, P.
    Jacquemyn, B.
    Luo, D.
    Ouwerkerk-Mahadevan, S.
    Vijgen, L.
    Van Eygen, V.
    Beumont, M.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (04) : 287 - 294